IRLAB Therapeutics AB vs SynapCell
IRLAB Therapeutics AB
A clinical-stage biopharma discovering and developing novel treatments for the most troublesome symptoms of Parkinson's
37 employees · est. 2013 · Sweden
SynapCell
Evaluate your most effective drug candidates in vivo using objective & translational measurements in the brain. #EEG
41 employees · est. 2005 · Boston, France
SynapCell is the older company (2013 vs 2005).
Side-by-Side Comparison
| Metric | IRLAB Therapeutics AB | SynapCell |
|---|---|---|
| Founded | ||
| Founded | 2013 | 2005 older |
| Headquarters | ||
| Headquarters | Sweden | Boston, France |
| Employees | ||
| Employees | 37 | 41 |
| Industry | ||
| Industry | Health Care, Health and Wellness | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Grant | Series A |
| Total Funding | ||
| Total Funding | $158.67M | $4.40M |
| Funding Rounds | ||
| Funding Rounds | 3 | 1 |
| Services | ||
| Services | Not tracked yet | Drug Efficacy Testing, Collaborative Projects, Preclinical EEG Lab Services, EEG Biomarker Analysis, Model Exploration |
| Target Customers | ||
| Target Customers | Not tracked yet | Pharmaceutical Companies, Biotechnology Firms, Neuroscience Researchers, Drug Discovery Teams, Academia in CNS Research |
| Taxonomy | ||
| Taxonomy | BiopharmaParkinson's DiseaseCNS DisordersDrug DiscoveryClinical-stageMesdopetam +9 | CNS Drug DevelopmentEEG BiomarkersNeurosciencePreclinical EvaluationDrug Discovery SolutionsCentral Nervous System +9 |
| Website | ||
| Website | irlab.se | synapcell.com |
About IRLAB Therapeutics AB
IRLAB Therapeutics AB is a clinical-stage biopharma company based in Sweden, specializing in the discovery and development of innovative treatments for Parkinson's and other CNS disorders. The company's flagship drug candidates, mesdopetam (IRL790) and pirepemat (IRL752), are currently in Phase IIb...
About SynapCell
SynapCell is a biotechnology company founded in 2005, specializing in drug efficacy evaluation at the preclinical stage using EEG-based methods. Their innovative approach provides drug developers with quantitative and unbiased endpoints through longitudinal monitoring of drug effects on translationa...
Also comparing in this category
Comparing more than these two?
Get IRLAB Therapeutics AB, SynapCell and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does IRLAB Therapeutics AB compare?
A PDF of IRLAB Therapeutics AB and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare IRLAB Therapeutics AB with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at IRLAB Therapeutics AB on 12 Sep 2024, and SynapCell on 11 Jun 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
